158 related articles for article (PubMed ID: 163687)
1. Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors.
Leung BS; Sasaki GH; Leung JS
Cancer Res; 1975 Mar; 35(3):621-7. PubMed ID: 163687
[TBL] [Abstract][Full Text] [Related]
2. Prolactin stimulation of estrogen receptor in vitro in 7,12 dimethylbenz(A)anthracene-induced mammary tumor.
Sasaki GH; Leung BS
Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):409-12. PubMed ID: 4369071
[No Abstract] [Full Text] [Related]
3. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
4. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
5. Specific estrogen binding in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
Boylan ES; Wittliff JL
Cancer Res; 1975 Mar; 35(3):506-11. PubMed ID: 163681
[TBL] [Abstract][Full Text] [Related]
6. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
[TBL] [Abstract][Full Text] [Related]
7. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Shafie SM; Hilf R
Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
[TBL] [Abstract][Full Text] [Related]
8. On the mechanism of prolactin and estrogen action in 7,12 dimethylbenz(A)anthracene-induced mammary carcinoma in the rat. II. In vivo tumor responses and estrogen receptor.
Leung BS; Sasaki GH
Endocrinology; 1975 Sep; 97(3):564-72. PubMed ID: 170065
[TBL] [Abstract][Full Text] [Related]
9. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
[TBL] [Abstract][Full Text] [Related]
10. Prolactin receptors in 7,12-dimethylbenz(a) anthracene-induced mammary tumors following endocrine ablation.
Costlow ME; Buschow RA; McGuire WL
Cancer Res; 1976 Nov; 36(11 Pt 1):3941-3. PubMed ID: 184919
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.
DeSombre ER; Kledzik G; Marshall S; Meites J
Cancer Res; 1976 Feb; 36(2 Pt 1):354-8. PubMed ID: 177195
[TBL] [Abstract][Full Text] [Related]
12. Hormones influencing postpartum growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
McCormick GM; Moon RC
Cancer Res; 1967 Apr; 27(4):626-31. PubMed ID: 6025728
[No Abstract] [Full Text] [Related]
13. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
14. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
Gibson SL; Hilf R
Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
[TBL] [Abstract][Full Text] [Related]
15. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors.
Rozhin J; Ludwig EH; Corombos J; Odden D; Horwitz JP; Hughes R; Hughes DE; Wilson E; Brooks SC
Cancer Res; 1983 Jun; 43(6):2611-7. PubMed ID: 6406049
[TBL] [Abstract][Full Text] [Related]
16. Prolactin-dependent rat mammary cancer: a model for man?
Pearson OH; Llerena O; Llerena L; Molina A; Butler T
Trans Assoc Am Physicians; 1969; 82():225-38. PubMed ID: 5375151
[TBL] [Abstract][Full Text] [Related]
17. Is there any association between elevated serum prolactin level and mammary adenocarcinoma induced by 7,12-dimethylbenz(alpha)anthracene.
Feuer G; Kellen JA; Kovacs K
Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):435-44. PubMed ID: 807960
[TBL] [Abstract][Full Text] [Related]
18. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
[TBL] [Abstract][Full Text] [Related]
19. Prolactin receptors and androgen-induced regression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
Costlow ME; Buschow RA; McGuire WL
Cancer Res; 1976 Sep; 36(9 pt.1):3324-9. PubMed ID: 184948
[TBL] [Abstract][Full Text] [Related]
20. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1977 Nov; 37(11):4070-4. PubMed ID: 409490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
